Navigation Links
NanoBio Wins 2007 Michigan Innovation Award
Date:10/5/2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)... Susan Knapp Pinnas, a leader of p...extensive diversified healthcare,experience, has ...twork, the,company announced today. , As a...nnas will be,responsible for advancing AvMed,s ov...inciples of strong relationships and service excel...
(Date:1/8/2009)...t Health and Education Act Mandates Label Accuracy..., WASHINGTON, Jan. 8 I...regarding dietary supplement regulation, the Natur...EO, David Seckman, released this statement: , ,... on steroid usage, which the Natural Products Asso...
(Date:1/8/2009)...ernment Officials Expect to Maintain or Increase S...uction of Roads and Bridges, Creation of 21st Cent...t Government Facilities , , SEATTLE, Jan. 8 /PR...a,s economic stimulus package outlines a significa...construction of roads and bridges, 21st-century sc...
(Date:1/8/2009)...uch more likely to be deadly for women and African...in the phenomenon account for only part of the dif... and male counterparts, according to results publi..., The results present a stark question for docto...the disease upon diagnosis don,t account for all t...
Breaking Medicine News(10 mins):Health News:Susan Knapp Pinnas Named AvMed Health Plans' New Senior Vice President of Network 2Health News:Natural Products Association Advocates Strength of Dietary Supplement Law 2Health News:Government at all Levels Will Continue to Spend on Essential Services and Invest in the Future, According to Onvia Study 2Health News:Government at all Levels Will Continue to Spend on Essential Services and Invest in the Future, According to Onvia Study 3Health News:Government at all Levels Will Continue to Spend on Essential Services and Invest in the Future, According to Onvia Study 4Health News:Why bladder cancer is deadlier for some 2Health News:Why bladder cancer is deadlier for some 3Health News:Why bladder cancer is deadlier for some 4
...i leaders have slammed claims that Maoris carry a ...nce, risky behaviour and criminal acts, terming su...ing to New Zealand researche, a genetic epidemiolo...rch, Dr Rod Lea and his colleagues, Maori men have...
...ies have shown that many call centre employees bet...tes, which is probably caused due to insulin malfu...conducted the study as an introduction to larger p...mic of diabetes has for a very long time worried t...
... daughters", the girls born to mothers who took th...time of pregnancy have an increased risk of breast...he August issue of the journal Cancer Epidemiology... DES daughters over age 40 had 1.9 times the risk ...
...IV-infected Indian worker in Bahrain died, days be... his family.// A free visa worker, Muthanna Posha... and tuberculosis he was suffering from, according...aily News newspaper. Officials in the Indian emba...
Other Medicine News:Health News:Warrior Gene Claims Slammed by Maori 2Health News:Warrior Gene Claims Slammed by Maori 3Health News:Studies Find That Call Centre Employees Could Be More Prone to Diabetes 2Health News:"DES Daughters" Have High Risk Of Breast Cancer 2Health News:"DES Daughters" Have High Risk Of Breast Cancer 3
(Date:12/27/2008)...FirstCall/ -- Warner Chilcott Limited (Nasdaq: W... and Mayne Pharma International Pty. Ltd. ("Mayne"...its against each of Mutual Pharmaceutical Company,...an") and Impax Laboratories, Inc. ("Impax") in th...r infringement of Mayne,s U.S. Patent No. 6,958,16...
(Date:12/17/2008)...alidation of non-animal alternative test methods ,...MatTek Corporation today announced that the ECVAM ...scientific validity of the Modified EpiDerm Skin I...C concluded that the Modified EpiDerm SIT has suff... of skin irritating and non-irritating test substa...
(Date:12/17/2008)...K Surgical, Inc., a medical,device company that h...on a,proprietary technology, announced today that...granted the company 510(k) clearance to market its...on of soft tissue during,plastic and reconstructi...opedic, arthroscopic, spinal and neurological surg...
(Date:12/17/2008)...ewswire-FirstCall/ -- NicOx,S.A. (NYSE Euronext P...pre-specified pooled analysis of 2,734 patients wi...pivotal phase 3 studies for naproxcinod. Both dose...n systolic and diastolic blood,pressure (SBP and ...e 13 week,period (p<0.001 for naproxcinod 750 ...
Breaking Medicine Technology:Warner Chilcott Files Lawsuits for Infringement of DORYX(R) Patent 2Warner Chilcott Files Lawsuits for Infringement of DORYX(R) Patent 3EpiDerm's Skin Irritation Test Fully Validated in European Union 2PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in Expanded Indications 2PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in Expanded Indications 3PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in Expanded Indications 4NicOx' Naproxcinod Shows Robust Blood Pressure Results in Phase 3 Pooled Analysis 2NicOx' Naproxcinod Shows Robust Blood Pressure Results in Phase 3 Pooled Analysis 3NicOx' Naproxcinod Shows Robust Blood Pressure Results in Phase 3 Pooled Analysis 4NicOx' Naproxcinod Shows Robust Blood Pressure Results in Phase 3 Pooled Analysis 5New Research Shows Dental Implants Require Significantly More Follow Up Treatment Than Root Canals 29768 1New Research Shows Dental Implants Require Significantly More Follow Up Treatment Than Root Canals 29768 2New Research Shows Dental Implants Require Significantly More Follow Up Treatment Than Root Canals 29768 3New Research Shows Dental Implants Require Significantly More Follow Up Treatment Than Root Canals 29768 4Dont Disturb Your Circadian Rhythm This Black Friday Sleep In Nap Later says Specialty Sleep Association 29766 1Dont Disturb Your Circadian Rhythm This Black Friday Sleep In Nap Later says Specialty Sleep Association 29766 2Wound Management Technologies Inc Announces FDA Clearance of 510k 29765 1Wound Management Technologies Inc Announces FDA Clearance of 510k 29765 2Wound Management Technologies Inc Announces FDA Clearance of 510k 29765 3Pharmaceutical Industry Needs to Speed Up Transformation to Meet Changing Market Dynamics According to Ernst 26 Young Report 29763 1Pharmaceutical Industry Needs to Speed Up Transformation to Meet Changing Market Dynamics According to Ernst 26 Young Report 29763 2Pharmaceutical Industry Needs to Speed Up Transformation to Meet Changing Market Dynamics According to Ernst 26 Young Report 29763 3Pharmaceutical Industry Needs to Speed Up Transformation to Meet Changing Market Dynamics According to Ernst 26 Young Report 29763 4
...007 - Pro-Pharmaceuticals,Inc. (Amex: PRW), a com...day updated the progress of its Phase II,clinical ...sectable,colorectal cancer patients who are unable...s Phase II clinical trial for first-line,treatment...dications may represent orphan drug status for DAV...
...ect Factor Xa Inhibitor,Shows a Significant Reduc...m Compared with Enoxaparin with Similarly Low Blee...Phase III clinical trial,data presented today at t...mostasis (ISTH) Congress demonstrate that once-dai...ficacy in the,prevention of venous thromboembolism...
Other Medicine Technology:Pro-Pharmaceuticals Updates Progress of Clinical Trials &,Davanat 505 (b)(2) Filings 2Pro-Pharmaceuticals Updates Progress of Clinical Trials &,Davanat 505 (b)(2) Filings 3Pro-Pharmaceuticals Updates Progress of Clinical Trials &,Davanat 505 (b)(2) Filings 4Pro-Pharmaceuticals Updates Progress of Clinical Trials &,Davanat 505 (b)(2) Filings 5Phase III Trial Results Show Superiority of Rivaroxaban over,Enoxaparin for the Prevention of Venous Thromboembolism in Patients,Undergoing Knee Replacement Surgery 2Phase III Trial Results Show Superiority of Rivaroxaban over,Enoxaparin for the Prevention of Venous Thromboembolism in Patients,Undergoing Knee Replacement Surgery 3Phase III Trial Results Show Superiority of Rivaroxaban over,Enoxaparin for the Prevention of Venous Thromboembolism in Patients,Undergoing Knee Replacement Surgery 4Phase III Trial Results Show Superiority of Rivaroxaban over,Enoxaparin for the Prevention of Venous Thromboembolism in Patients,Undergoing Knee Replacement Surgery 5
Duckbill. 3.5 mm tip. Light curve.
2 mm. Angled 13 degrees, 15 mm from angle to tip. Round handle.
2 mm curved tip. Round handle. Designated most popular model or size.
Large. Double-ended. 3 mm pointed end and 5 mm angled end.
Medicine Products: